Aliskiren: Preclinical evidence for the treatment of hyperproliferative skin disorders-Reference-Cited by-同舟云学术

Aliskiren: Preclinical evidence for the treatment of hyperproliferative skin disorders

Published:2018-08 Issue: Volume:104 Page:151-157
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Pawloski Priscila Lúcia,Moreira Camila Guimarães,Horinouchi Cintia Delai Silva,Fernandes Daniel,Olchanheski Luiz Renato,Machado Willian,Cabrini Daniela Almeida,Dietrich Michele,Paludo Kátia,Otuki Michel Fleith

Funder

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference32 articles.

1. Latitude and psoriasis prevalence;Jacobson;J. Am. Acad. Dermatol.,2011

2. The genetics of psoriasis: a complex disorder of the skin and immune system;Bhalerao;Hum. Mol. Genet.,1998

3. Observations of psoriasis in the absence of therapeutic intervention identifies two unappreciated morphologic variants, thin-plaque and thick-plaque psoriasis, and their associated phenotypes;Christensen;J. Invest. Dermatol.,2006

4. Pathogenesis and therapy of psoriasis;Lowes;Nature,2007

5. Combined use of systemic agents for psoriasis: a systematic review;Busard;JAMA Dermatol.,2014

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macroscopic, biochemical and hystological evaluation of topical anti-inflammatory activity of Casearia sylvestris (Flacourtiaceae) in mice;Journal of Ethnopharmacology;2021-01

2. The role of the renin‐angiotensin system in skin physiology and pathophysiology;Experimental Dermatology;2020-09